VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 510 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2014. The put-call ratio across all filers is 1.37 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $286,000 | -58.2% | 10,871 | +61.5% | 0.06% | -39.4% |
| Q4 2015 | $684,000 | -39.1% | 6,730 | +6.9% | 0.10% | -50.5% |
| Q3 2015 | $1,123,000 | -15.2% | 6,293 | +5.6% | 0.21% | -25.3% |
| Q2 2015 | $1,324,000 | -55.6% | 5,962 | -60.3% | 0.28% | -30.6% |
| Q1 2015 | $2,982,000 | -68.0% | 15,014 | -76.9% | 0.40% | -83.7% |
| Q4 2014 | $9,313,000 | +10.9% | 65,076 | +1.7% | 2.49% | +33.4% |
| Q3 2014 | $8,394,000 | +13.9% | 63,978 | +9.5% | 1.87% | +50.9% |
| Q2 2014 | $7,368,000 | +1728.3% | 58,420 | +1810.4% | 1.24% | +2071.9% |
| Q1 2014 | $403,000 | +20.7% | 3,058 | +7.6% | 0.06% | +14.0% |
| Q4 2013 | $334,000 | +11.0% | 2,843 | -1.5% | 0.05% | +8.7% |
| Q3 2013 | $301,000 | +106.2% | 2,886 | +69.9% | 0.05% | -4.2% |
| Q2 2013 | $146,000 | – | 1,699 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |